Sertraline and Lepirudin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordLepirudin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Taking sertraline and lepirudin together can raise your risk of bleeding. Sertraline is an antidepressant (an SSRI), and one thing it does is make your platelets, the tiny cells that help your blood clot, a little less sticky. Lepirudin is a blood thinner. When you put those two together, your blood has an even harder time clotting.
This can show up as easy bruising, nosebleeds, or, more rarely, serious bleeding. The good news is that your care team knows how to handle this. They can watch you more closely for signs of bleeding. Please don't stop either medicine on your own. Just talk with your pharmacist or doctor if you notice anything unusual.
Effect: Additive increased bleeding risk (pharmacodynamic, not a prodrug or CYP issue).
- Mechanism: SSRIs like sertraline deplete platelet serotonin, impairing serotonin-mediated platelet aggregation and hemostasis; this adds to the anticoagulant effect of lepirudin, a direct thrombin inhibitor.
- Direction/magnitude: Increased bleeding potential; magnitude not precisely quantified.
- Onset: Delayed. Evidence: Probable (case-control/cohort data with SSRIs plus anticoagulants).
- Management: Monitor for bleeding (epistaxis, ecchymosis, hematoma, petechiae, overt hemorrhage), track aPTT/hemostatic parameters per lepirudin protocol, and counsel the patient. Dose may be individualized by the care team.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn them about this elevated bleeding risk.1. Hemostasis depends in part on platelets releasing serotonin. Studies using case-control and cohort designs have demonstrated that taking SSRIs (for example, sertraline) alongside anticoagulants correlates with a greater chance of bleeding 231. Using sertraline at the same time as an anticoagulant may increase the likelihood of bleeding. Among the bleeding events documented are ecchymosis, epistaxis, petechiae, hematoma, and hemorrhages that can be life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
This combination can be used with care and monitoring. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise.
- Your team may watch you more closely for bleeding, especially since lepirudin is a strong blood thinner given in a monitored setting.
- Your doses may need to be adjusted and individualized by your care team.
- Watch for and report nosebleeds, unusual bruising, small red skin spots, blood in urine or stool, or bleeding that won't stop.
Raise any of these signs with your pharmacist or prescriber right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) found a higher risk of clinically relevant bleeding (defined as hospital admission for bleeding) in patients taking warfarin for atrial fibrillation while also receiving SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched with randomly selected patients who received warfarin alone (n=117). The SSRIs included FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleedings over 586.4 treatment years. The corresponding overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. The hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009) versus warfarin alone. The SSRIs involved in patients who bled during concurrent use were sertraline or citalopram. Adding an SSRI was not linked to any change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The findings may be limited by prior bleeding events, unknown patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking concurrent selective serotonin reuptake inhibitors (SSRIs) found an increased risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also on a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients taking SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) A non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers evaluated sertraline's effect on the plasma protein binding of warfarin. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or placebo group; sertraline was titrated up from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and periodically afterward. The investigators concluded that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown an association between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on published observational study data, exposure to SSRIs, especially in the month prior to delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events linked to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Lepirudin together?
Sertraline and lepirudin together add up to a higher bleeding risk, so watch for bruising or bleeding and report it. Keep taking both as prescribed and let your care team monitor and adjust as needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Lepirudin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Lepirudin interaction managed?
This combination can be used with care and monitoring. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Your team may watch you more closely for bleeding, especially since lepirudin is a strong blood thinner given in a monitored setting. Your doses may need to be adjusted and individualized by your care team. Watch for and report nosebleeds, unusual bruis… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Lepirudin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Lepirudin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist